2,5-Dimethoxy-4-(propylthio)benzeneethanamine, ydrochloride
- CAS No.
- 850140-15-7
- Chemical Name:
- 2,5-Dimethoxy-4-(propylthio)benzeneethanamine, ydrochloride
- Synonyms
- 2C-T-7.HCl;2C-T-7 (hydrochloride);2C-T-7 (hydrochloride) (exempt preparation);2C-T-7.HCl, 1mg/ml in Methanol (as free base);2,5-Dimethoxy-4-propylthio-phenylethylamine HCl (2-CT-7);2,5-Dimethoxy-4-(propylthio)phenethylamine Hydrochloride;2,5-Dimethoxy-4-(propylthio)benzeneethanaminehydrochloride;2,5-Dimethoxy-4-(propylthio)benzeneethanamine, ydrochloride;2,5-Dimethoxy-4-(propylsulfanyl)phenethylamine Hydrochloride;2-[2,5-dimethoxy-4-(propylthio)phenyl]ethanamine hydrochloride
- CBNumber:
- CB31013040
- Molecular Formula:
- C13H22ClNO2S
- Molecular Weight:
- 291.83
- MDL Number:
- MFCD09751326
- MOL File:
- 850140-15-7.mol
- MSDS File:
- SDS
| Flash point | 2℃ |
|---|---|
| storage temp. | -20°C |
| solubility |
DMF: 20 mg/ml DMSO: 16 mg/ml Ethanol: 11 mg/mlPBS (pH 7.2): 5 mg/ml |
| FDA UNII | 70O70T990D |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS02,GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H302+H332-H319 | |||||||||
| Precautionary statements | P210-P305+P351+P338 | |||||||||
| Hazard Codes | F,Xn | |||||||||
| Risk Statements | 11-20/21/22-36 | |||||||||
| Safety Statements | 16-26-36/37 | |||||||||
| RIDADR | UN 1648 3 / PGII | |||||||||
| WGK Germany | 2 | |||||||||
| NFPA 704 |
|
2,5-Dimethoxy-4-(propylthio)benzeneethanamine, ydrochloride price More Price(12)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 11200 | 2C-T-7 (hydrochloride) ≥98% | 850140-15-7 | 5mg | $62 | 2026-04-30 | Buy |
| Cayman Chemical | 15672 | 2C-T-7 (hydrochloride) (exempt preparation) ≥98% | 850140-15-7 | 1mg | $69 | 2026-04-30 | Buy |
| Cayman Chemical | 11200 | 2C-T-7 (hydrochloride) ≥98% | 850140-15-7 | 10mg | $94 | 2026-04-30 | Buy |
| Cayman Chemical | 11200 | 2C-T-7 (hydrochloride) ≥98% | 850140-15-7 | 50mg | $355 | 2026-04-30 | Buy |
| Usbiological | 010158 | 2,5-Dimethoxy-4-(propylsulfanyl)phenethylamine Hydrochloride | 850140-15-7 | 25mg | $446 | 2026-06-03 | Buy |
2,5-Dimethoxy-4-(propylthio)benzeneethanamine, ydrochloride Chemical Properties, Uses, Production
Description
A series of 2,5-
Uses
Phenethylamine derivative. Inhibits monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B)
References
[1] MARKUS R MEYER Hans H M. Metabolism of designer drugs of abuse: an updated review.[J]. Current drug metabolism, 2010, 11 5: 468-482. DOI: 10.2174/138920010791526042
[2] ARIANE WOHLFARTH Sebastian D Wolfgang Weinmann. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum[J]. Analytical and Bioanalytical Chemistry, 2010, 396 7: 2403-2414. DOI: 10.1007/s00216-009-3394-4
[3] RAIMONDO BRUNO . Emerging psychoactive substance use among regular ecstasy users in Australia[J]. Drug and alcohol dependence, 2012, 124 1: Pages 19-25. DOI: 10.1016/j.drugalcdep.2011.11.020
[4] PABLO R MOYA. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 321 3: 1054-1061. DOI: 10.1124/jpet.106.117507
[5] FUMIKO NAGAI Kanako S H K Ryouichi Nonaka. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain[J]. European journal of pharmacology, 2007, 559 2: Pages 132-137. DOI: 10.1016/j.ejphar.2006.11.075
